-
Mashup Score: 32
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: stanford.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 190Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish - 3 day(s) ago
In the high-stakes arena of drug discovery, the journey from bench to bedside is hindered by a daunting 92% failure rate, primarily due to unpredicted toxicities and inadequate therapeutic efficacy in clinical trials. The FDA Modernization Act 2.0 heralds a transformative approach, advocating for the integration of alternative methods to conventional animal testing, including cell-based assays that employ human induced pluripotent stem cell (iPSC)-derived organoids, and organ-on-a-chip technologies, in conjunction with sophisticated artificial intelligence (AI) methodologies. Our review explores the innovative capacity of iPSC-derived clinical trial in a dish models designed for cardiovascular disease research. We also highlight how integrating iPSC technology with AI can accelerate the identification of viable therapeutic candidates, streamline drug screening, and pave the way toward more personalized medicine. Through this, we provide a comprehensive overview of the current landscape
Source: www.annualreviews.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 31
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: stanford.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 31
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: stanford.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 32
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: stanford.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 29
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: stanford.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 58SDDS 2025: Stanford Drug Discovery Symposium - 3 month(s) ago
Join us for the 2025 Stanford Drug Discovery Symposium! SDDS 2025 will be a cornerstone in the drug discovery community for networking and collaboration.
Source: med.stanford.eduCategories: General Medicine News, CardiologistsTweet-
Excited to announce registration for #SDDS2025 (April 28-29, 2025) is open! Join us for cutting-edge insights in #DrugDiscovery from industry, FDA, academia, and VC. https://t.co/dF7GOTPf3L @StanfordCVI @StanfordMed @Stanford_ChEMH @StanfordHealth @DrCaliff_FDA @CarolynBertozzi https://t.co/dgwvgbfvJ7
-
-
Mashup Score: 86Unraveling the Heart of Long COVID - 3 month(s) ago
by Amanda Chase, PhD October 14, 2024 COVID-19 first appeared as a respiratory illness, infecting millions and causing a global pandemic. It has since become clear that COVID-19 has a broader impacts than initially thought, with the potential to affect multiple organs, particularly the cardiovascular system. The lasting effects of COVID-19 have also become an area of increasing concern, with millions of patients experiencing lingering symptoms that can persist for months or years. Much about long COVID
Source: med.stanford.eduCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 148Clinical trials in-a-dish for cardiovascular medicine - 5 month(s) ago
Abstract. Cardiovascular diseases persist as a global health challenge that requires methodological innovation for effective drug development. Conventional
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 26Simulations Reveal Optimal Strategy for Surgery - 5 month(s) ago
The aorta is the primary vessel for blood flow from your heart to your body – and that blood flow is controlled by the aortic valve. Some babies are born with a congenital heart defect of the aortic valve, and patients with a particularly severe heart defect are sometimes treated by a new surgical procedure called bicuspidization. In bicuspidization, the surgeon cuts the diseased valve and sews in patches to construct a new valve. However, one problem that frequently occurs after the surgery is stenosis:
Source: med.stanford.eduCategories: General Medicine News, CardiologistsTweet
Please join @StanfordCVI seminar on Tue 11/26 at 12pm PST by Dr. Dennis Discher @UofPenn @theNCI speak on #nucleus #genome #cytosketal #matrix #axis https://t.co/8AeY0xJojr @StanfordDeptMed @Stanford_ChEMH @SeanM_Wu @BCVSearlyCareer @StanfordEng @AHAScience @ATVBEarlyCareer https://t.co/Acny6ZxDhQ